Nomura SPARX Invests in LinqMed | NOMURA
Summary
"LinqMed is advancing multiple clinical trial pipelines using QSTs patented technology for the exclusive rights to mass produce and stabilize the radioactive isotope copper-64 (64Cu), which could previously only be manufactured in small quantities for diagnostic purposes. In the future, the company is also considering overseas expansion through licensing agreements with global pharmaceutical companies and U.S. firms involved in the manufacture, development, and distribution of radioactive pharmaceuticals.NSPI expects LinqMed to effectively allocate capital and achieve medium-term growth as a pioneer in the development of copper-64 (64Cu), realizing theragnostics that integrate diagnostics and therapeutics in the development of radioactive pharmaceuticals expected to be the next generation of anti-cancer treatments.Nomura SPARX Investment, Inc. (NSPI) is an asset management company jointly established in April 2021 by Nomura Holdings, Inc. and SPARX Group Co., Ltd. NSPI brings together Nomura Groups deep expertise in IPOs and other services supporting the growth of unlisted companies, and SPARX Groups solid track record in the asset management business, including its venture capital business that invests in unlisted company stock. However, the principal amount invested in stocks and other securities is not guaranteed, and there is a risk that the value of the stocks and other securities invested in may fluctuate due to the bankruptcy of the issuing company or changes in its business performance or financial conditions, or due to changes in economic and social conditions inside or outside Japan, as well as changes in market conditions such as interest rate levels and quotations on financial instruments markets, and as a result, you may incur losses. Please read the prospectus, product brochures and other documents delivered in relation to individual NSPI Services carefully before entering into an actual transaction, and make sure to do so based on your own judgment and responsibility. Trade name: Nomura SPARX Investment, Inc. Financial Instruments Business Operator, Director-General of the Kanto Local Finance Bureau (Kinsho) No.3274 Membership: The Investment Trusts Association, JapanThe contents of this material are based on an English translation of a Japanese announcement made on April 9, 2025 by NSPI.